Journal profile · Medicine-Public Health, Environmental and Occupational Health
IJID Regions
ISSN 2772-7076 · Elsevier · United Kingdom
IJID Regions: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.3 (journal website); fully open access; APC about USD 1,380; median 98 days to acceptance (121 articles, last 24 months); 281 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
IJID Regions is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies and Tuberculosis Research and Epidemiology, together about 22.1% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Official Publication of the International Society for Infectious Diseases IJID Regions is an official journal of the International Society for Infectious Diseases (ISID). IJID Regions aims to publish high-quality, evidence-based infectious disease science of regional interest and relevance. It seeks to enhance visibility of national and regional research, with a focus on those infectious diseases that are common in under-resourced countries and settings. The journal also welcomes studies on regions within developed nations. We publish research that can be utilized by national and regional health clinicians, scientists, health systems, and public health policy makers.IJID Regions focuses on clinical infectious diseases, clinical epidemiology and public health. Publishing original clinical and laboratory-based research, together with reports of clinical trials and reviews dealing with the epidemiology, clinical diagnosis, treatment, and control of infectious diseases. We encourage authors to collaborate between institutions to ensure good sample size and firm conclusions. Prospective, randomised controlled trials are preferred over retrospective, descriptive studies.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Public Health, Environmental and Occupational Health
Editor-in-chief Eskild PetersenPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named South Africa 8, United States 5, United Kingdom 4, Thailand 2, Mainland China 1 (32 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- SARS-CoV-2 and COVID-19 ResearchMedicine7.8%
- COVID-19 Clinical Research StudiesMedicine7.5%
- Tuberculosis Research and EpidemiologyMedicine6.9%
- Mosquito-borne diseases and controlMedicine6.1%
- Antibiotic Use and ResistanceImmunology and Microbiology5.9%
- COVID-19 epidemiological studiesMathematics5.5%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology5.1%
- Viral Infections and Outbreaks ResearchMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 3LetPub ·
- CiteScore (publisher)
- 3Publisher website ·
- SJR 2026-06
- 0.67LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 24OpenAlex ·
- i10-index
- 141OpenAlex ·
- 2-year mean citedness
- 2.2OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 99.82%LetPub ·
Volume
- Articles per year
- 227LetPub ·
Articles by year OpenAlex count · 1,004 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 189 | 189 | 36 |
| 2025 | 281 | 281 | 478 |
| 2024 | 194 | 194 | 946 |
| 2023 | 134 | 134 | 975 |
| 2022 | 159 | 159 | 1,506 |
| 2021 | 47 | 47 | 489 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
98 daysMedian, submission to acceptance · P25–P75 56 days – 130 days
- Acceptance to online
- median 3 days (121 articles)
- Submission to online
- median 102 days
- Sample
- 121 articles with submission and acceptance dates (489 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 44 daysPublisher website ·
- Submission to acceptance
- 57 daysPublisher website ·
- Acceptance to publication
- 4 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,380 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 1,380 / EUR 1,290 / GBP 1,100 / JPY 171,160 | — | — | |
| LetPub | USD 1,200 | Yes | — | |
| Publisher website | USD 1,590 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- 150–200 words
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required, 3
- Highlights
- Required
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted15, with length limits
- brief reportOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
- case reportOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
- correspondenceOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
- correspondence (letter to the editor)Correspondence (Letter to the Editor) is reserved for comments on papers recently published (within 3 months by volume) in the Journal. Maximum length 400 words…Length not stated
- editorialEditorial: Representing the International Journal of Infectious Diseases' viewpoints, each editorial is written in-house by the journal's editorial team and may…Length not stated
- hypothesisOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
- letter to the editorOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
- medical imageryMedical Imagery: We invite submission of high-quality, interesting and instructive images (such as clinical and other photographs, figures or diagrams, photomic…Length not stated
- meta-analysisOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
- opinionOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
- original articleOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…main text ≤ 3,500 words
- perspectiveOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
- review articleOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…main text ≤ 4,000 words
- short communicationOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
- systematic reviewOriginal articles cover research on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of internat…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interest
Corresponding authors, on behalf of all the authors of a submission, must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other …
Source ↗Publisher website ·- Publication ethics
Human subjects work must be carried out in accordance with the Declaration of Helsinki. Model summary
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving hu
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.
Source ↗Publisher website ·- Open access Open Access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process; papers deemed suitable are typically sent to a minimum of three independent expert reviewers. Model summary
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of three independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Edito…
Source ↗Publisher website ·- Preprints Preprints
Preprints can be shared anywhere at any time; sharing will not count as prior publication. Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2772-7076
- Society / sponsor
- International Society for Infectious Diseases
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about IJID Regions
What CAS zone is IJID Regions in?
In the 2025 upgraded edition of the CAS Journal Ranking, IJID Regions is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of IJID Regions?
The journal's website gives an impact factor of 2.3; this is the journal's own figure, as LetPub lists none for it; CiteScore 3, h-index 24.
How long does peer review take at IJID Regions?
Based on the dates recorded on 121 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 56–130 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of IJID Regions?
According to the journal's author guidelines: Abstract: 150–200 words; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required, 3; Highlights: Required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of IJID Regions based?
Of the 32 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are South Africa (8), United States (5) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index IJID Regions?
According to LetPub and DOAJ records, IJID Regions is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PMC; that list has not been checked against each database.
Is IJID Regions open access, and what is the APC?
IJID Regions is a fully open-access journal. APC about USD 1,380.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .